Clin2
NCT07070895Possibly a fitRecruiting

Wellness app for chronic cough study

Refractory Chronic CoughUnexplained Chronic CoughCough Hypersensitivity

Part of Lungs & breathing clinical trials.

This trial tests a smartphone app and a smartwatch to help people with chronic cough that hasn't improved with standard care. You'll wear a watch to track your cough and use the app to learn management techniques.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
21 years and older
Study type
Interventional

Who can take part

  • You are 21 years or older.
  • You have had a cough for at least 8 weeks that is mostly dry (no mucus at least half the time).
  • You have had a normal chest X-ray or CT scan for your cough.
  • You have seen a doctor for your cough and tried standard treatments, but they didn't help enough.
  • You are willing to wear a smartwatch daily and fill out questionnaires.
  • You do not smoke or vape, and you have not coughed up blood or had certain lung conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06706765Recruiting· Early Phase 1
Cough suppression therapy via group telehealth

This study tests a behavioral therapy delivered through group video calls to help people with a chronic dry cough that has no clear cause. It may offer a non-drug way to reduce coughing.

Missoula, Montana
NCT07483489Not yet recruiting· Phase 2
HW091077 for hard-to-treat chronic cough

This trial tests a new medicine, HW091077, for people who have had a chronic cough for at least a year that hasn't gotten better with treatment or has no clear cause. It aims to see if the drug can help reduce coughing.

NCT07650084Recruiting· Phase 3
Testing BLU-5937 for hard-to-treat chronic cough

This 24-week study tests whether a new medicine called BLU-5937 can help adults whose chronic cough hasn't improved with standard treatments. Chronic cough that lasts a year or longer can seriously affect quality of life, and this trial explores whether this drug might provide relief.

Leshan, Sichuan
NCT06960759Recruiting· Phase 2
Cough suppression therapy for chronic cough

This study tests a behavior-based therapy to help you gain control over a persistent cough that hasn't responded to other treatments. You will learn techniques to reduce coughing during a 4-week program.

Aurora, Colorado
NCT07671924Recruiting· Phase 2
Testing nalbuphine extended-release for chronic cough

This trial tests whether an extended-release medication called nalbuphine can reduce coughing in people with chronic cough that hasn't improved with other treatments. You may be eligible if you've had a persistent cough for at least a year and have already tried treatments for conditions that could cause it.

Ajax
NCT06376448Recruiting
Chronic cough study using a new questionnaire

This study aims to better understand different types of chronic cough by using a new questionnaire. If you have had a cough for at least 8 weeks and do not smoke, you may be able to help.

Cottingham, East Yorkshiure

Hear when a new Refractory Chronic Cough trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.